Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
boston blog main
boston top stories
clinical trials
deals
2
×
life sciences
national blog main
national top stories
alexion pharmaceuticals
allosteric
alnylam pharmaceutials
arrowhead pharmaceuticals
atlas venture
atopic dermatitis
autoimmune disorders
boehringer ingelheim
brace pharma
cleva pharma
dicerna pharmaceuticals
drug discovery
dupilumab
eli lilly
glaxosmithkline
hepatitis b
hotspot therapeutics
indiana blog main
indiana top stories
investing
johnson & johnson
jonathan montagu
metabolic diseases
mrl ventures fund
neurodegenerative diseases
primary hyperoxaluria
rna interference
san francisco blog main
san francisco top stories
sanofi
sofinova parnters
What
ago
2
×
medicines
2
×
abandoning
address
adds
allosteric
baggage
clinic
companies
cuts
deal
development
dicerna
disease
elusive
free
gets
hotspot
interference
long
molecules
new
path
pharma
potential
rna
rnai
set
signs
small
steer
targets
therapeutics
wasn’t
ways
years
Language
unset
Current search:
ago
×
deals
×
medicines
×
@xconomy.com
3 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
